000 | 01818 a2200481 4500 | ||
---|---|---|---|
005 | 20250513054528.0 | ||
264 | 0 | _c19940719 | |
008 | 199407s 0 0 eng d | ||
022 | _a0300-8428 | ||
024 | 7 |
_a10.1007/BF00788678 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaumgart, D | |
245 | 0 | 0 |
_aCharacterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain. _h[electronic resource] |
260 |
_bBasic research in cardiology _c |
||
300 |
_a61-79 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta _xphysiology |
650 | 0 | 4 |
_aAzetidines _xpharmacology |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aElectric Stimulation |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aIsomerism |
650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
650 | 0 | 4 |
_aOuabain _xpharmacology |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 |
_aSodium Channels _xdrug effects |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
700 | 1 | _aEhring, T | |
700 | 1 | _aKrajcar, M | |
700 | 1 | _aSkyschally, A | |
700 | 1 | _aHeusch, G | |
773 | 0 |
_tBasic research in cardiology _gvol. 89 _gno. 1 _gp. 61-79 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00788678 _zAvailable from publisher's website |
999 |
_c8010271 _d8010271 |